Mutation in gene IDH a possible target for AML treatment
Many patients with acute myeloid leukemia (AML) share a mutation in a gene called IDH. A University of Colorado Cancer Center study shows that this IDH mutation may be the first domino in a chain that leads to a more aggressive form of the disease. ‘In fact, it’s not IDH itself that causes the problem,’ […]
